Medigene: Transition To Prominent Immunotherapy Player – Investing.com
|
Medigene: Transition To Prominent Immunotherapy Player
Investing.com Medigene’s (DE:MDG1k) H1 results are in line with our expectations and represent the completion of its transformation into a prominent T-cell immunotherapy player. Highlights from H1 include submission of a clinical trial authorisation (CTA) to begin … |
|
Healing Osteoarthritis with Stem Cells
Anti Aging News Emory Orthopaedics and Spine Center physicians made waves five years ago when they launched regenerative stem cell therapy. This is a form of treatment for OA as well as related joint maladies. It makes use of the patient’s stem cells to remedy damaged … |
|
Allergy Immunotherapy Market Foreseen to Draw USD 4324.7 Million by 2023 at 10.85% of CAGR: Declares MRFR
Markets Insider PUNE, India, Aug. 3, 2017 /PRNewswire/ — Market Research Future published a Cooked research report on “Global Allergy Immunotherapy Market Research Report – Forecast to 2023″ – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Sublingual Allergy Immunotherapy Market Foreseen to Grow Exponentially Over 2017 – 2025satPRnews (press release) |
|
Allergy Immunotherapy Market Foreseen to Draw USD 4324.7 Million by 2023 at 10.85% of CAGR: Declares MRFR
Markets Insider PUNE, India, Aug. 3, 2017 /PRNewswire/ — Market Research Future published a Cooked research report on “Global Allergy Immunotherapy Market Research Report – Forecast to 2023″ – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Sublingual Allergy Immunotherapy Market Foreseen to Grow Exponentially Over 2017 – 2025satPRnews (press release) |
|
European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release) BILLERICA, Mass., Aug. 3, 2017 /CNW/ — MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology used in a … |
PR Newswire (press release) |
European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
PR Newswire (press release) Merck’s patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR. The patent will give Merck’s CRISPR genomic integration technology broad protection, further strengthening the company’s … |